Join the international myotonic dystrophy research community at the 15th meeting of the International Myotonic Dystrophy Consortium (IDMC-15)! The event will take place from May 26th to May 30th 2026, in the picturesque Saguenay—Lac-Saint-Jean region in Quebec. View Preliminary Programme or View Guidelines.

The annual conference of the International Myotonic Dystrophy Consortium brings together world-renowned experts, researchers, healthcare professionals, patient advocates, people living with the disease and representatives from the pharmaceutical industry to share their knowledge and collaborate on neuromuscular disease research.

A maximum of four abstracts will be selected for oral presentations. Each selected abstract will be presented in a 10-minute talk with a 5-minute discussion.

We welcome submissions from academic, clinical, and industry, including:

• New or updated results from clinical trials or observational studies
• Translational or biomarker discoveries
• Innovative therapeutic approaches
• Findings with potential impact on clinical practice or patient outcomes

Submission requirements

• Abstracts must include recent, unpublished, non-public data
• Submissions are open to academic, clinical, and industry-led studies
• Selected authors will be notified in advance to allow preparation

All submissions will undergo expedited review by the scientific committee, based on scientific quality, novelty, and relevance.

This session offers a unique platform to share cutting-edge findings and accelerate progress in myotonic dystrophy research and care. For More Information:

Visit the Event Website or IDMC-15 on LinkedIn!